硬膜下导管注射组织型纤溶酶原激活剂治疗急性-on-慢性硬膜下血肿引流后残余血肿:2例新病例报告
本文报告2例急性-on-慢性硬膜下血肿行开颅术后经硬膜下导管注射重组组织型纤溶酶原激活剂(rtPA)的病例。两例患者经治疗后硬膜下引流改善、临床与影像学好转并成功出院。作者认为硬膜下溶栓治疗可促进血肿清除,可能为微创引流策略创造条件,但证据匮乏,安全性和有效性仍需更多研究。
要点
- 急性硬膜下血肿术后残余血肿可导致再手术,并限制微创引流策略的应用。
- 两例急性-on-慢性硬膜下血肿开颅术后经硬膜下导管注射rtPA,引流改善且临床影像好转。
- 硬膜下溶栓可能促进微创选项,但证据不足,需更多研究验证安全性和有效性。
核心结论
- 硬膜下溶栓治疗可改善血肿清除,可能促进因清除不充分而暂缓的微创选项如钻孔开颅。
- 证据匮乏,需更多研究证实安全性和有效性、优化技术并指导患者选择。
研究设计与样本
- 病例报告,纳入2例急性-on-慢性硬膜下血肿患者。
- 两例均因精神状态改变行急诊开颅术,术后经硬膜下导管注射重组组织型纤溶酶原激活剂。
主要发现
- 第一例78岁男性术后硬膜下引流不畅,出现癫痫发作及新发急性硬膜下血肿证据,术后第3天经硬膜下导管注射rtPA。
- 第二例64岁男性术后接受rtPA。
- 两例随后均获得良好硬膜下引流、临床与影像学改善,并成功出院至专业护理机构。
临床怎么用
- 对于急性-on-慢性硬膜下血肿开颅术后残余血肿且引流不佳者,可考虑经硬膜下导管局部注射rtPA,但需个体化评估。
- 该技术可能为后续微创引流创造条件,但目前非常规推荐,应在充分知情和监测下谨慎使用。
局限性
- 仅2例病例报告,证据级别低,无法确立安全性和有效性。
- 缺乏对照和长期随访,患者选择标准和技术细节尚未明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Residual hematoma after operative management of acute subdural hematoma contributes to reoperation and is cited as a reason for deferment of less invasive drainage strategies. Although local antithrombolytic therapy has been studied in intracerebral hemorrhage and chronic subdural hematoma, to date there are no reports of recombinant tissue plasminogen activator for residual hematoma post drainage for acute subdural hematoma. CASE DESCRIPTION: Two patients presented with altered mental status secondary to acute-on-chronic subdural hematomas and underwent emergent craniotomies. The first, a 78-year-old man, had poor subdural drain output and deteriorated with seizures and evidence of new acute subdural hematoma formation. Recombinant tissue plasminogen activator was injected through the subdural catheter on postoperative day 3. The second patient, a 64-year-old male, received recombinant tissue plasminogen activator postoperatively. Subsequently, both experienced good subdural drainage, clinical and radiologic improvement, and successful discharge to a skilled nursing facility. CONCLUSIONS: Subdural thrombolytic therapy can improve hematoma evacuation. A potential implication of this is facilitation of minimally invasive options such as twist-drill craniotomy, previously deferred due to inadequate evacuation. However, there is a paucity of evidence and more research is needed to substantiate the safety and efficacy, refine this technique, and guide patient selection.
引用
- Lam J, Lee DJ, Oladunjoye A, et al. Subdural Catheter Injection of Tissue Plasminogen Activator for Residual Hematoma Post Drainage of Acute-on-Chronic Subdural Hematoma: Novel Case Report of 2 Patients. World Neurosurg. 2019. PMID: 31605861. doi:10.1016/j.wneu.2019.10.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。